In light of the pivotal role of NLRP3 inflammasome in DCM, we used NLRP3-miRNA in vivo to explore whether downregulation of NLRP3 could prevent the pathogenesis of DCM. This evidence concerns the gene NLRP3 and familial dilated cardiomyopathy.